MIRA Pharmaceuticals, Inc. (MIRA)

USD 1.05

(-1.87%)

Total Assets Summary of MIRA Pharmaceuticals, Inc.

MIRA Pharmaceuticals, Inc.'s latest annual total assets in 2023 was 4.93 Million USD , up 474.83% from previous year.
MIRA Pharmaceuticals, Inc.'s latest quarterly total assets in 2024 Q2 was 3.01 Million USD , down -20.83% from previous quarter.
MIRA Pharmaceuticals, Inc. reported annual total assets of 858.07 Thousand USD in 2022, down -74.43% from previous year.
MIRA Pharmaceuticals, Inc. reported annual total assets of 3.35 Million USD in 2021, up 11773.32% from previous year.
MIRA Pharmaceuticals, Inc. reported quarterly total assets of 3.01 Million USD for 2024 Q2, down -20.83% from previous quarter.
MIRA Pharmaceuticals, Inc. reported quarterly total assets of 4.93 Million USD for 2023 FY, up 474.83% from previous quarter.

Annual Total Assets Chart of MIRA Pharmaceuticals, Inc. (2023 - 2020)

Historical Annual Total Assets of MIRA Pharmaceuticals, Inc. (2023 - 2020)

Year	Total Assets	Total Assets Growth
2023	4.93 Million USD	474.83%
2022	858.07 Thousand USD	-74.43%
2021	3.35 Million USD	11773.32%
2020	28.25 Thousand USD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	3.8 Million USD	-22.78%
2024 Q2	3.01 Million USD	-20.83%
2023 FY	4.93 Million USD	474.83%
2023 Q2	3.82 Million USD	862.1%
2023 Q1	397.58 Thousand USD	-53.67%
2023 Q4	4.93 Million USD	-45.31%
2023 Q3	9.01 Million USD	135.76%
2022 Q4	858.07 Thousand USD	0.0%
2022 FY	858.07 Thousand USD	-74.43%
2022 Q3	- USD	0.0%
2022 Q1	3.17 Million USD	0.0%
2021 Q1	- USD	0.0%
2021 FY	3.35 Million USD	11773.32%
2020 FY	28.25 Thousand USD	0.0%

Peer Total Assets Comparison of MIRA Pharmaceuticals, Inc.

Name	Total Assets	Total Assets Difference
Amgen Inc.	97.15 Billion USD	99.995%
AstraZeneca PLC	101.11 Billion USD	99.995%
Biogen Inc.	26.84 Billion USD	99.982%
Gilead Sciences, Inc.	62.12 Billion USD	99.992%
Scilex Holding Company	101.3 Million USD	95.131%
Scilex Holding Company	101.3 Million USD	95.131%